Search

Your search keyword '"Freedman M"' showing total 2,260 results

Search Constraints

Start Over You searched for: Author "Freedman M" Remove constraint Author: "Freedman M"
2,260 results on '"Freedman M"'

Search Results

102. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

103. Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI)

104. Prevalence of homologous recombination deficiency (HRD)-related signatures indicates that a wider range of prostate cancer patients may benefit from PARP-inhibitor therapy

107. A Pilot Randomized Controlled Trial of a Mindfulness Program for Filipino Children

109. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

110. Sodium intake and multiple sclerosis activity and progression in BENEFIT

111. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

112. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

113. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

114. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort

115. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions (vol 9, 4079, 2018)

116. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

117. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

119. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study

121. Mechanical behaviour and failure phenomenon of an in situ toughened silicon nitride

128. The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis.

129. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

130. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

131. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions.

132. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

133. The Role of S-Adenosylmethionine in Improving Cognitive Performance in Healthy Mice and Alzheimer’s Disease Mice: a Meta Analysis

144. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

146. Rising Tide, Grey Tsunami: Charting the History of a Dangerous Metaphor

147. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

148. A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

149. Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Catalog

Books, media, physical & digital resources